ECTRIMS eLearning

The influence of coping on long-term employment in multiple sclerosis - a prospective study
Author(s): ,
N Grytten
Affiliations:
Norwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital;KG Jebsen MS Research Centre, Institute of Clinical Medicine, University of Bergen
,
A.B.R Skår
Affiliations:
Norwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital
,
J Aarseth
Affiliations:
The Norwegian Multiple Sclerosis Centre
,
J Assmus
Affiliations:
Centre for clinical research, Haukeland University Hospital, Bergen
,
E Farbu
Affiliations:
Department of Neurology, Stavanger University Hospital;Neuroscience Research Group, Stavanger University Hospital, Stavanger;Institute of Clinical Medicine, University of Bergen, Bergen
,
K Lode
Affiliations:
Department of Research, Stavanger University Hospital, Stavanger
,
H Nyland
Affiliations:
Institute of Clinical Medicine, University of Bergen, Bergen
,
T Smedal
Affiliations:
Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital, Bergen, Norway;Norwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital0
K.-M Myhr
Affiliations:
KG Jebsen MS Research Centre, Institute of Clinical Medicine, University of Bergen;Norwegian Multiple Sclerosis Competence Centre, Haukeland University HospitalNorwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital
ECTRIMS Learn. Grytten N. 09/16/16; 146687; P847
Nina Grytten
Nina Grytten
Contributions
Abstract

Abstract: P847

Type: Poster

Abstract Category: Clinical aspects of MS - Epidemiology

Background: Provided the importance of coping and advantageous adjustments to multiple sclerosis (MS) for health and psychological wellbeing, we hypothesized that coping could have an independent effect on long-term employment status.

The aim was to investigate the influence of coping styles, clinical and demographic factors on employment status during a 13 years follow-up in patients with newly diagnosed MS.

Method: All patients (n=108) recently diagnosed with MS were invited to participate in the long-term follow-up study in 2002. A total of 93 patients agreed to participate of whom 52 were unemployed at time of inclusion in 2002. Forty-one were part or full time employed and followed up with regard to employment status until 2015. At baseline, the study included disability scoring (EDSS), fatigue (FSS), depression (BDI), time delay from onset to diagnosis and questionnaire assessing coping (the COPE scale). Logistic regression analysis was used to identify factors that were independently associated with being unemployed at baseline, and cox regression analysis were used to identify factors at baseline that were independently associated with time to unemployment during follow up.

Results: A total of 41 (44%) were employed at baseline, and after 13 years, 22 (23%) patients were still part- or full time employed. Older age at diagnosis, female gender and depression were associated with patients being unemployed at baseline, and female gender, long time delay from onset to diagnosis and denial as avoidant coping strategy at baseline predicted shorter time to unemployment.

Conclusions: Avoidant coping style, female gender and long time delay of diagnosis were associated with shorter time to unemployment. In order to improve long-term employment in MS, these factors should be considered by health professionals and at the patient`s work place.

Disclosure: Nina Grytten: nothing to disclose

Anne Britt Rundhovde Skår: has served on scientific advisory boards for Novartis Norway, Biogen Idec and Genzyme and received speaker honoraria from Genzyme, Novartis, Biogen Idec and Teva.

Jan Aarseth: nothing to disclose

Jurg Assmus: nothing to disclose

Elisabeth Farbu:

Honoraria for:Ad boards: Novartis, Biogen, GenzymeLectures: Novartis, Genzyme, Biogen, TevaUnrestricted grant: Novartis

Kristin Lode: nothing to disclose

Harald Nyland: nothing to disclose

Tori Smedal: nothing to disclose

Kjell-Morten Myhr: has served on scientific advisory boards for Novartis Norway, Biogen Idec, Genzyme and Roche; received speaker honoraria from Genzyme, Sanofi-Aventis, Novartis, Biogen Idec and Teva; and received unrestricted research support from Sanofi-Aventis, Novartis, Biogen Idec, and the Norwegian MS Society.



Abstract: P847

Type: Poster

Abstract Category: Clinical aspects of MS - Epidemiology

Background: Provided the importance of coping and advantageous adjustments to multiple sclerosis (MS) for health and psychological wellbeing, we hypothesized that coping could have an independent effect on long-term employment status.

The aim was to investigate the influence of coping styles, clinical and demographic factors on employment status during a 13 years follow-up in patients with newly diagnosed MS.

Method: All patients (n=108) recently diagnosed with MS were invited to participate in the long-term follow-up study in 2002. A total of 93 patients agreed to participate of whom 52 were unemployed at time of inclusion in 2002. Forty-one were part or full time employed and followed up with regard to employment status until 2015. At baseline, the study included disability scoring (EDSS), fatigue (FSS), depression (BDI), time delay from onset to diagnosis and questionnaire assessing coping (the COPE scale). Logistic regression analysis was used to identify factors that were independently associated with being unemployed at baseline, and cox regression analysis were used to identify factors at baseline that were independently associated with time to unemployment during follow up.

Results: A total of 41 (44%) were employed at baseline, and after 13 years, 22 (23%) patients were still part- or full time employed. Older age at diagnosis, female gender and depression were associated with patients being unemployed at baseline, and female gender, long time delay from onset to diagnosis and denial as avoidant coping strategy at baseline predicted shorter time to unemployment.

Conclusions: Avoidant coping style, female gender and long time delay of diagnosis were associated with shorter time to unemployment. In order to improve long-term employment in MS, these factors should be considered by health professionals and at the patient`s work place.

Disclosure: Nina Grytten: nothing to disclose

Anne Britt Rundhovde Skår: has served on scientific advisory boards for Novartis Norway, Biogen Idec and Genzyme and received speaker honoraria from Genzyme, Novartis, Biogen Idec and Teva.

Jan Aarseth: nothing to disclose

Jurg Assmus: nothing to disclose

Elisabeth Farbu:

Honoraria for:Ad boards: Novartis, Biogen, GenzymeLectures: Novartis, Genzyme, Biogen, TevaUnrestricted grant: Novartis

Kristin Lode: nothing to disclose

Harald Nyland: nothing to disclose

Tori Smedal: nothing to disclose

Kjell-Morten Myhr: has served on scientific advisory boards for Novartis Norway, Biogen Idec, Genzyme and Roche; received speaker honoraria from Genzyme, Sanofi-Aventis, Novartis, Biogen Idec and Teva; and received unrestricted research support from Sanofi-Aventis, Novartis, Biogen Idec, and the Norwegian MS Society.



By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies